Qualgro

Qualgro is a Singapore-based early-growth venture firm with an explicit B2B data, software, and AI thesis, deploying $1M-$5M cheques at Series A and Series B across Southeast Asia and selectively into Australia and India. The firm has built a recognisable book of B2B SaaS and AI healthcare investments and operates with a partner team that combines local SEA depth with global SaaS pattern recognition. For founders, Qualgro is best positioned as a regional Series A and B lead for B2B health software and AI clinical tools with paid customers and multi-country ambitions. The right founder profile is a SEA, Australian, or Indian operator building enterprise health IT, RCM, EHR, AI-enabled clinical workflow, or health data infrastructure with $1-5M ARR, durable retention, and credible international expansion signals. Founders running consumer wellness, asset-heavy clinic chains, or pre-revenue plays should not approach. Entry path is via a Qualgro portfolio CEO, the Singapore enterprise SaaS founder community, or warm introductions from co-investing regional and US funds (Wavemaker, Vertex, Openspace, Tiger). In the pitch, lead with ARR, gross retention by cohort, sales productivity, AI capability validated through enterprise adoption, and a credible Series B plan that names likely international leads. Caveats: Qualgro runs an institutional process with deep customer and reference checks, and term sheets carry standard governance provisions including board representation. Cycle times are months. SEA’s healthcare regulatory and payer fragmentation will be probed thoroughly, and founders should be ready to discuss multi-country go-to-market sequencing. Confirm reserves and follow-on policy explicitly given the firm’s preference for concentrated positions across Series A and B.